MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

Cited by (957)

Items 201–300 of 957

  1. The emerging role of micro RNA s in cardiovascular disease
    Lars Mäegdefessel · 2014 · Journal of Internal Medicine
  2. Genome-Wide and Species-Wide In Silico Screening for Intragenic MicroRNAs in Human, Mouse and Chicken
    Irena Godnic, Minja Zorc, Daša Jevšinek Skok, George A. Călin, Simon Horvat, Peter Dovč, Milena Kovač, Tanja Kunej · 2013 · PLoS ONE
  3. Unappreciated diversification of stem archosaurs during the Middle Triassic predated the dominance of dinosaurs
    Christian Foth, Martín D. Ezcurra, Roland B. Sookias, Stephen L. Brusatte, Richard J. Butler · 2016 · BMC Evolutionary Biology
  4. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review
    Mohammed Altigani Abdalla, Harshal Deshmukh, Stephen Lawrence Atkin, Thozhukat Sathyapalan · 2020 · Life Sciences
  5. MicroRNAs in bovine adipogenesis: genomic context, expression and function
    Josué Moura Romão, Weiwu Jin, Maolong He, Tim Angus McAllister, Le Luo Guan · 2014 · BMC Genomics
  6. Investigational agent MLN9708/2238 targets tumor-suppressor miR33b in MM cells
    Tian, Ze, Zhao, Jian-jun, Tai, Yu-Tzu, Amin, Samir B., Hu, Yiguo, Berger, Allison J., Richardson, Paul, Chauhan, Dharminder, Anderson, Kenneth C. · 2012 · Blood
  7. Integrated mRNA and micro RNA profiling reveals epigenetic mechanism of differential sensitivity of Jurkat T cells to AgNPs and Ag ions
    Hyun-Jeong Eom, Nivedita Chatterjee, Jeong‐Soo Lee · 2014 · Toxicology Letters
  8. Anti-atherogenic mechanisms of high density lipoprotein: Effects on myeloid cells
    Andrew James Murphy, Marit Westerterp, Laurent Yvan‐Charvet, Alan R. Tall · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  9. New Insights on Intermediary Metabolism for a Better Understanding of Nutrition in Teleosts
    Stéphane Panserat, Lucie Marandel, Iban Seiliez, Sandrine Cassy · 2018 · Annual Review of Animal Biosciences
  10. miRNAs link metabolic reprogramming to oncogenesis
    Maria Hatziapostolou, Christos Polytarchou, Dimitrios Iliopoulos · 2013 · Trends in Endocrinology and Metabolism
  11. MicroRNAs regulating lipid metabolism in atherogenesis
    Katey J. Rayner, Carlos F Fernandez-Hernando, Kathryn J. Moore · 2012 · Thrombosis and Haemostasis
  12. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease
    Filipe V. Duarte, Carlos M. Palmeira, Anabela Pinto Rolo · 2015 · Advances in experimental medicine and biology
  13. miR-155 in the Resolution of Atherosclerosis
    Robyn Bruen, Stephen Fitzsimons, Orina Belton · 2019 · Frontiers in Pharmacology
  14. Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver
    C. Lisa Kurtz, Emily E. Fannin, Cynthia L. Toth, Daniel S. Pearson, Kasey C. Vickers, Praveen Sethupathy · 2015 · Scientific Reports
  15. Chronic Administration of Proanthocyanidins or Docosahexaenoic Acid Reversess the Increase of miR-33a and miR-122 in Dyslipidemic Obese Rats
    Laura Baselga‐Escudero, Anna Arola‐Arnal, Aïda Pascual‐Serrano, Aleix Ribas‐Latre, Ester Casanova, M. Josepa Salvadó, Lluı́s Arola, Cinta Bladé · 2013 · PLoS ONE
  16. MicroRNA-539 Is Up-regulated in Failing Heart, and Suppresses O-GlcNAcase Expression
    Senthilkumar Muthusamy, Angelica M. DeMartino, Lewis J. Watson, Kenneth R. Brittian, Ayesha Zafir, Sujith Dassanayaka, Kyung U. Hong, Steven Paul Jones · 2014 · Journal of Biological Chemistry
  17. A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease
    Michael B. Fessler · 2017 · Annals of the American Thoracic Society
  18. A MicroRNA Linking Human Positive Selection and Metabolic Disorders
    Lifeng Wang, Nasa Sinnott-Armstrong, Alexandre Wagschal, Abigail R. Wark, João Paulo Camporez, Rachel J. Perry, Fei Ji, Yoojin Sohn, Justin D. Oh, Su Wu et al. · 2020 · Cell
  19. Epigenetic Regulation of Adipogenesis in Development of Metabolic Syndrome
    Richa Pant, Priyanka Firmal, Vibhuti Kumar Shah, Aftab Alam, Samit Chattopadhyay · 2021 · Frontiers in Cell and Developmental Biology
  20. Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4
    Ming Cui, Zelin Xiao, Baodi Sun, Yue Wang, Minying Zheng, Lihong Ye, Xiaodong Zhang · 2014 · Biochemical and Biophysical Research Communications
  21. Oxidative stress in atherosclerosis: The role of microRNAs in arterial remodeling
    Anna Zampetaki, Katarzyna Dudek, Manuel Mayr · 2013 · Free Radical Biology and Medicine
  22. Aerobic endurance training improves nonalcoholic fatty liver disease (NAFLD) features via miR-33 dependent autophagy induction in high fat diet fed mice
    Parvin Ghareghani, Mehrnoosh Shanaki, Saeideh Ahmadi, Alireza Khoshdel, Neda Rezvan, Reza Meshkani, Maryam Delfan, Sattar Gorgani‐Firuzjaee · 2017 · Obesity Research & Clinical Practice
  23. miRNA Targeting of Oxysterol Binding Protein-like 6 (OSBPL6) Regulates Cholesterol Trafficking and Efflux
    M. Ouimet, E. Hennessy, C. van Solingen, G. Koelwyn, Maryem Hussein, Bhama Ramkhelawon, Katey J. Rayner, Ryan E. Temel, L. Perisic, U. Hedin et al. · 2016 · Arteriosclerosis, Thrombosis and Vascular Biology
  24. Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival
    Débora Rosa Bublik, Slađana Bursać, Michal Sheffer, Ines Oršolić, Tali Shalit, Ohad Tarcic, Eran Kotler, Odelia Mouhadeb, Yonit Hoffman, Gilad Fuchs et al. · 2016 · Proceedings of the National Academy of Sciences
  25. A microRNA’s journey to the center of the mitochondria
    Anne M. Macgregor-Das, Samarjit Das · 2018 · American Journal of Physiology-Heart and Circulatory Physiology
  26. Comprehensive overview and assessment of computational prediction of microRNA targets in animals
    Xiao Fan, Lukasz Kurgan · 2014 · Briefings in Bioinformatics
  27. microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator
    Jiang, Huajun, Zhang, Jin, Du, Yu, Jia, Xiaojian, Yang, Fan, Si, Shuyi, Wang, Li, Hong, Bin · 2015 · Atherosclerosis
  28. Translational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granules
    Khosrow Adeli · 2011 · American Journal of Physiology-Endocrinology and Metabolism
  29. Cholesterol regulation of receptor‐interacting protein 140 via microRNA‐33 in inflammatory cytokine production
    Ping-Chih Ho, Kun-Che Chang, Ya-Shan Chuang, Li-Na Wei · 2011 · The FASEB Journal
  30. An miRNA-mediated therapy for SCA6 blocks IRES-driven translation of the CACNA1A second cistron
    Yu Miyazaki, Xiaofei Du, Shin‐ichi Muramatsu, Christopher Manuel Gomez · 2016 · Science Translational Medicine
  31. Diabetic Cardiomyopathy: An Immunometabolic Perspective
    Paras Kumar Mishra, Wei Ying, Shyam Sundar Nandi, Gautam Kumar Bandyopadhyay, Kaushik P. Patel, Sushil Kumar Mahata · 2017 · Frontiers in Endocrinology
  32. SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression
    Vergnes, Laurent, Chin, Robert G., de Aguiar Vallim, Thomas, Fong, Loren G., Osborne, Timothy F., Young, Stephen G., Reue, Karen · 2016 · Journal of Lipid Research
  33. Perturbed microRNA Expression by Mycobacterium tuberculosis Promotes Macrophage Polarization Leading to Pro-survival Foam Cell
    Pankaj Kumar Ahluwalia, Rajan Kumar Pandey, Prabodh Kumar Sehajpal, Vijay Kumar Prajapati · 2017 · Frontiers in Immunology
  34. microRNA-33 deficiency in macrophages enhances autophagy, improves mitochondrial homeostasis, and protects against lung fibrosis
    Ahangari, Farida, Price, Nathan L., Malik, Shipra, Chioccioli, Maurizio, Bärnthaler, Thomas, Adams, Taylor S., Kim, Jooyoung, Pradeep, Sai Pallavi, Ding, Shuizi, Cosmos, Carlos et al. · 2023 · JCI Insight
  35. miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice
    Goedeke, Leigh, Rotllan, Noemi, Ramírez, Cristina M., Aranda, Juan F., Canfrán-Duque, Alberto, Araldi, Elisa, Fernández-Hernando, Ana, Langhi, Cedric, de Cabo, Rafael, Baldán, Ángel et al. · 2015 · Atherosclerosis
  36. miR-183 functions as an oncogene by targeting ABCA1 in colon cancer
    DA-PENG BI, Yin Cheng-hua, Xiaoyue Zhang, Nana Yang, XU Jiayou · 2016 · Oncology Reports
  37. Statin-Induced Decrease in ATP-Binding Cassette Transporter A1 Expression via microRNA33 Induction may Counteract Cholesterol Efflux to High-Density Lipoprotein
    Eric J. Niesor, Gregory G. Schwartz, Anne Perez, Andrea Stauffer, Alexandre Durrwell, Gabriela Suchánková, Renée Benghozi, Markus Abt, David G. Kallend · 2015 · Cardiovascular Drugs and Therapy
  38. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia
    Ann‐Kathrin Eisfeld, Guido Marcucci, Kati S. Maharry, Sebastian Schwind, Michael D. Radmacher, Deedra Nicolet, Heiko Becker, Krzysztof Mrózek, Susan P. Whitman, Klaus Hans Metzeler et al. · 2012 · Blood
  39. Noncoding microRNAs: small RNAs play a big role in regulation of ADME?
    Ai‐Ming Yu, Yuzhuo Pan · 2012 · Acta Pharmaceutica Sinica B
  40. MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1
    Chuankai Zhang, Yunda Zhang, Weiji Ding, Yancheng Lin, Zhengjie Huang, Qi Luo · 2015 · Protein & Cell
  41. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol
    Masataka Nishiga, Takahiro Horie, Yasuhide Kuwabara, Kazuya Nagao, Osamu Baba, Tetsushi Nakao, Tomohiro Nishino, Daihiko Hakuno, Yasuhiro Nakashima, Hitoo Nishi et al. · 2016 · Circulation Research
  42. Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP
    Zhang, Li, Rajbhandari, Prashant, Priest, Christina, Sandhu, Jaspreet, Wu, Xiaohui, Temel, Ryan, Castrillo, Antonio, de Aguiar Vallim, Thomas Q, Sallam, Tamer, Tontonoz, Peter · 2017 · eLife
  43. HDL abnormalities in familial hypercholesterolemia: Focus on biological functions
    Shiva Ganjali, Amir Abbas Momtazi‐Borojeni, Maciej Banach, Petri T. Kovanen, Evan A. Stein, Amirhossein Sahebkar · 2017 · Progress in Lipid Research
  44. A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle
    Motoharu Awazawa, Paula Gabel, Eva Tsaousidou, Hendrik Nolte, Marcus Krüger, Joel Schmitz, Philipp Ackermann, Claus Brandt, Janine Altmüller, Susanne Motameny et al. · 2017 · Nature Medicine
  45. A Database of Gene-Environment Interactions Pertaining to Blood Lipid Traits, Cardiovascular Disease and Type 2 Diabetes
    Yu‐Chi Lee, Chao‐Qiang Lai, José María Ordovás, Laurence D. Parnell · 2011 · Journal of Data Mining in Genomics & Proteomics
  46. Therapeutic inhibition of miR-33 promotes fatty acid oxidation but does not ameliorate metabolic dysfunction in diet-induced obesity
    D. Karunakaran, Laura Richards, M. Geoffrion, Danyk Barrette, Ryan J. Gotfrit, M. Harper, Katey J. Rayner · 2015 · Arteriosclerosis, Thrombosis and Vascular Biology
  47. RETRACTED ARTICLE: MircoRNA-33a inhibits epithelial-to-mesenchymal transition and metastasis and could be a prognostic marker in non-small cell lung cancer
    Lihua Yang, Jie Yang, Jingqiu Li, Xingkai Shen, Yanping Le, Chengwei Zhou, Shaomin Wang, Shun Zhang, Dazhi Xu, Zhaohui Gong · 2015 · Scientific Reports · Retracted
  48. MiR-181a regulates lipid metabolism via IDH1
    B. Chu, Ting Wu, L. Miao, Y. Mei, Mian Wu · 2015 · Scientific Reports
  49. MicroRNA-33 regulates the innate immune response via ATP binding cassette transporter-mediated remodeling of membrane microdomains
    Lai, Lihua, Azzam, Kathleen M., Lin, Wan-Chi, Rai, Prashant, Lowe, Julie M., Gabor, Kristin A., Madenspacher, Jennifer H., Aloor, Jim J., Parks, John S., Näär, Anders M. et al. · 2016 · Journal of Biological Chemistry
  50. Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis.
    N. Price, V. Miguel, W. Ding, Abhishek K. Singh, Shipra Malik, N. Rotllan, A. Moshnikova, Jakub Toczek, C. Zeiss, M. Sadeghi et al. · 2019 · JCI Insight
  51. Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease
    Yuhao Zhang, Xixiang Cheng, Zhiqiang Lu, Jingkun Wang, Hongyan Chen, Weiwei Fan, Xin Gao, Jin Li · 2012 · Diabetes Research and Clinical Practice
  52. Metabolic mechanisms for and treatment of NAFLD or NASH occurring after liver transplantation
    Amedeo Lonardo, Alessandro Mantovani, Salvatore Petta, Amedeo Carraro, Christopher D. Byrne, Giovanni Targher · 2022 · Nature Reviews Endocrinology
  53. Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy
    Sabine Traver, Saïd Assou, E. Scalici, D. Haouzi, T. Al-Edani, S. Belloc, S. Hamamah · 2014 · Human Reproduction Update
  54. Antagonism of Betulinic Acid on LPS-Mediated Inhibition of ABCA1 and Cholesterol Efflux through Inhibiting Nuclear Factor-kappaB Signaling Pathway and miR-33 Expression
    Guo-Jun Zhao, Shilin Tang, Yun-Cheng Lv, Xin-Ping Ouyang, Pingping He, Feng Yao, Wujun Chen, Qian Lu, Yanyan Tang, Min Zhang et al. · 2013 · PLoS ONE
  55. MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases
    Juan Francisco Aranda, Julio Madrigal‐Matute, Noemí Rotllán, Carlos F Fernandez-Hernando · 2013 · Free Radical Biology and Medicine
  56. MicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1
    Zheng Chen, Jing Ye, Usama Ashraf, Yunchuan Li, Siqi Wei, Shengfeng Wan, Ali Zohaib, Yunfeng Song, Huanchun Chen, Shengbo Cao · 2016 · Journal of Virology
  57. Circulating microRNAs as biomarkers for metabolic disease
    Marcelina Párrizas, Anna Novials · 2016 · Best Practice & Research Clinical Endocrinology & Metabolism
  58. Bergamot (Citrus bergamia Risso) Flavonoids and Their Potential Benefits in Human Hyperlipidemia and Atherosclerosis: an Overview
    Anna Rita Cappello, Vincenza Dolce, Domenico Iacopetta, M. Martello, Marco Fiorillo, Rosita Curcio, Luigina Muto, Dhanyalayam Dhanya · 2016 · Mini-Reviews in Medicinal Chemistry
  59. MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
    Emma L. Solly, Catherine G. Dimasi, Christina A. Bursill, Peter James Psaltis, Joanne T. M. Tan · 2019 · Journal of Clinical Medicine
  60. miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19
    Asha Acharya, Daniel C. Berry, He Zhang, Yuwei Jiang, Benjamin T. Jones, Robert E. Hammer, Jonathan M. Graff, Joshua T. Mendell · 2019 · Genes & Development
  61. MicroRNAs mediated environmental stress responses and toxicity signs in teleost fish species
    Sayed Haidar Abbas Raza, Sameh A. Abdelnour, Mashael Alhumaidi Alotaibi, Qwait AlGabbani, Mohammed A. E. Naiel, Borhan Shokrollahi, Ahmed Elsayed Noreldin, Ali Raza Jahejo, Mujahid Ali Shah, Mahmoud M. Alagawany et al. · 2021 · Aquaculture
  62. Enemy or partner: Relationship between intronic micrornas and their host genes
    Xu Gao, Yu Qiao, Dong Hee Han, Yanfen Zhang, Ning Ma · 2012 · IUBMB Life
  63. Micro-RNAs and High-Density Lipoprotein Metabolism
    Alberto Canfrán‐Duque, Chin‐Sheng Lin, Leigh Goedeke, Yajaira Suárez, Carlos F Fernandez-Hernando · 2016 · Arteriosclerosis Thrombosis and Vascular Biology
  64. Function and regulation of ABCA1 – membrane meso‐domain organization and reorganization
    Kohjiro Nagao, Maiko Tomioka, Kazumitsu Ueda · 2011 · FEBS Journal
  65. A screen in mice uncovers repression of lipoprotein lipase by microRNA‐29a as a mechanism for lipid distribution away from the liver
    Aras N. Mattis, Guisheng Song, Kelly Hitchner, Roy Y. Kim, Andrew Y. Lee, Amar Deep Sharma, Yann Malato, Michael T. McManus, Christine Esau, Erich Koller et al. · 2014 · Hepatology
  66. The study of a barley epigenetic regulator, HvDME, in seed development and under drought
    Aliki Kapazoglou, Vicky Drosou, Anagnostis Argiriou, Athanasios S. Tsaftaris · 2013 · BMC Plant Biology
  67. MicroRNAs in obesity-associated disorders
    Eugenio J. Abente, Murugan Subramanian, Vimal Ramachandran, Seyed Hani Najafi-Shoushtari · 2015 · Archives of Biochemistry and Biophysics
  68. Anti-CD38 Antibody Therapy: Windows of Opportunity Yielded by the Functional Characteristics of the Target Molecule
    Antonella Chillemi, Gianluca Zaccarello, Valeria Quarona, Manuela Ferracin, Chiara Ghimenti, Massimo Massaia, Alberto L. Horenstein, Fabio Malavasi · 2013 · Molecular Medicine
  69. MicroRNA regulation of macrophages in human pathologies
    Yuanyuan Wei, Andreas Schober · 2016 · Cellular and Molecular Life Sciences
  70. mi RNA s, polyphenols, and chronic disease
    Cinta Bladé, Laura Baselga‐Escudero, M. Josepa Salvadó, Anna Arola‐Arnal · 2012 · Molecular Nutrition & Food Research
  71. MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes
    F. Kostopoulou, K. Malizos, I. Papathanasiou, A. Tsezou · 2015 · Arthritis Research & Therapy
  72. Revisiting the metabolic syndrome and paving the way for micro RNA s in non‐alcoholic fatty liver disease
    Duarte M. S. Ferreira, André Lopes Simão, Cecília M. P. Rodrigues, Rui Eduardo Castro · 2014 · FEBS Journal
  73. Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells
    Zhuojian Li, Pai-Huai Ou-Yang, Xing-Peng Han · 2013 · Cellular Signalling
  74. Maternal low-protein diet causes epigenetic deregulation of HMGCR and CYP7α1 in the liver of weaning piglets
    Rihua Cong, Yimin Jia, Runsheng Li, Yingdong Ni, Xiaojing Yang, Qinwei Sun, Nahid Parvizi, Ruqian Zhao · 2012 · The Journal of Nutritional Biochemistry
  75. Therapeutic Action of Fluoxetine is Associated with a Reduction in Prefrontal Cortical miR-1971 Expression Levels in a Mouse Model of Posttraumatic Stress Disorder
    Ulrike Schmidt, Leonie Herrmann, Kathrin Hagl, Božidar Novak, Christine W. Huber, Florian Holsboer, Carsten Tobias Wotjak, Dominik R. Buell · 2013 · Frontiers in Psychiatry
  76. Lychee pulp phenolics ameliorate hepatic lipid accumulation by reducing miR-33 and miR-122 expression in mice fed a high-fat diet
    Dongxiao Su, Ruifen Zhang, Fangli Hou, Jianwei Chi, Fei Huang, Shijuan Yan, Lei Liu, Yuanyuan Deng, Zhencheng Wei, Mingwei Zhang · 2017 · Food & Function
  77. Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age.
    F. Martino, Fabrizio Carlomosti, D. Avitabile, L. Persico, M. Picozza, F. Barilla', M. Arca, A. Montali, E. Martino, C. Zanoni et al. · 2015 · Clinical science
  78. Identification and characterization of differentially expressed miRNAs in subcutaneous adipose between Wagyu and Holstein cattle
    Juntao Guo, Xiuxiu Zhang, Wanlong Huang, Xiangyang Miao · 2017 · Scientific Reports
  79. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention
    Agostino Di Ciaula, David Q.‐H. Wang, Piero Portincasa · 2018 · Expert Review of Gastroenterology & Hepatology
  80. Identification and Functional Analysis of Epigenetically Silenced MicroRNAs in Colorectal Cancer Cells
    Hongli Yan, Ae-Jin Choi, Byron Lee · 2011 · PLoS ONE
  81. SREBP-1c/MicroRNA 33b Genomic Loci Control Adipocyte Differentiation
    Nathan L. Price, Brandon Holtrup, Stephanie L. Kwei, Martin Wabitsch, Matthew S. Rodeheffer, Laurence Bianchini, Yajaira Suárez, Carlos F Fernandez-Hernando · 2016 · Molecular and Cellular Biology
  82. MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy
    Mohammad Mohajeri, Maciej Banach, Stephen Lawrence Atkin, Alexandra E. Butler, Massimiliano Ruscica, Gerald Francis Watts, Amirhossein Sahebkar · 2018 · Trends in Pharmacological Sciences
  83. Targeting Immune Senescence in Atherosclerosis
    Danusha Michelle Vellasamy, Sin-Jye Lee, Khang Wen Goh, Bey Hing Goh, Yin-Quan Tang, Long Chiau Ming, Wei Hsum Yap · 2022 · International Journal of Molecular Sciences
  84. microRNAs and HDL life cycle
    Alberto Canfrán‐Duque, Cristina M. Ramírez, Leigh Goedeke, Chin‐Sheng Lin, Carlos F Fernandez-Hernando · 2014 · Cardiovascular Research
  85. Chlamydia pneumoniae negatively regulates ABCA1 expression via TLR2-Nuclear factor-kappa B and miR-33 pathways in THP-1 macrophage-derived foam cells
    Guo-Jun Zhao, Zhongcheng Mo, Shilin Tang, Xin-Ping Ouyang, Pingping He, Yun-Cheng Lv, Feng Yao, Yu-lin Tan, Wei Xie, Jinfeng Shi et al. · 2014 · Atherosclerosis
  86. ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview
    E. Arrigoni, Sara Galimberti, Mario Petrini, Romano Danesi, Antonello Di Paolo · 2016 · Expert Opinion on Drug Metabolism & Toxicology
  87. miR-142 controls metabolic reprogramming that regulates dendritic cell activation
    Yaping Sun, Katherine I. Oravecz-Wilson, Sydney Bridges, Richard C. McEachin, Julia J. Wu, Stephanie H. Kim, Austin Taylor, Cynthia K. Zajac, Hideaki Fujiwara, Daniel Peltier et al. · 2019 · Journal of Clinical Investigation
  88. Changes of Circulating MicroRNAs in Response to Treatment With Teriparatide or Denosumab in Postmenopausal Osteoporosis
    Athanasios D. Anastasilakis, Polyzois Makras, Maria I. Pikilidou, Symeon Tournis, Konstantinos Makris, Ilias Bisbinas, O. Tsave, John G. Yovos, Maria P. Yavropoulou · 2017 · The Journal of Clinical Endocrinology & Metabolism
  89. Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders
    Zhenyu Yao, Wenbin Chen, Shanshan Shao, Shizhan Ma, Chongbo Yang, Meng-zhu Li, Jiajun Zhao, Ling Gao · 2018 · Journal of Zhejiang University SCIENCE B
  90. Targeting and therapeutic peptides in nanomedicine for atherosclerosis
    Eun Ji Chung · 2016 · Experimental Biology and Medicine
  91. microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application
    Véronique Desgagné, Luigi Bouchard, Renée Guérin · 2016 · Clinical Chemistry and Laboratory Medicine (CCLM)
  92. Deciphering Non-coding RNAs in Cardiovascular Health and Disease
    Anindita Das, Arun Samidurai, Fadi N. Salloum · 2018 · Frontiers in Cardiovascular Medicine
  93. Dual targeted delivery of statins and nucleic acids by chitosan-based nanoparticles for enhanced antiatherosclerotic efficacy
    Ting Jiang, Lu Xu, Mengxin Zhao, Fei Kong, Xinrong Lu, Cui Tang, Chunhua Yin · 2021 · Biomaterials
  94. Eyeballing cholesterol efflux and macrophage function in disease pathogenesis
    Abdoulaye Sène, Rajendra S. Apte · 2013 · Trends in Endocrinology and Metabolism
  95. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
    Teresa Auguet, Gemma Aragonès, Alba Berlanga, Esther Guiu‐Jurado, Andreu Martí, Salomé Martínez, Fàtima Sabench, Mercè Hernández, Carmen Aguilar, Juan J. Sirvent et al. · 2016 · International Journal of Molecular Sciences
  96. Epigenome-wide association study of triglyceride postprandial responses to a high-fat dietary challenge
    Chao‐Qiang Lai, Mary K. Wojczynski, Laurence D. Parnell, Bertha Hidalgo, Marguerite R. Irvin, Stella W. Aslibekyan, Michael A. Province, Devin Absher, Donna K. Arnett, José María Ordovás · 2016 · Journal of Lipid Research
  97. c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer
    Zhiyong Li, Ying Xie, Mingxia Deng, Leqing Zhu, Xiaobin Wu, Guangqiang Li, Nan-Xi Shi, Chuangyu Wen, Weicai Huang, Yuanyuan Duan et al. · 2021 · Cancer Letters
  98. Circulating miRNAs associated with nonalcoholic fatty liver disease
    Amila Iriskic Atic, Maja Sofie Thiele, Alexander Munk, Louise T. Dalgaard · 2023 · American Journal of Physiology-Cell Physiology
  99. Key events in cancer: Dysregulation of SREBPs
    Yunkuo Li, Shouwang Wu, Xiaodong Zhao, Shiming Hao, Faping Li, Yu-Xiong Wang, Bin Liu, Difei Zhang, Yishu Wang, Honglan Zhou · 2023 · Frontiers in Pharmacology
  100. Relevance of microRNA in metabolic diseases
    Nathan L. Price, Cristina M. Ramírez, Carlos F Fernandez-Hernando · 2014 · Critical Reviews in Clinical Laboratory Sciences